Related Experiment Video
Updated: Mar 5, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Identifying high-risk post-infarction patients by autonomic testing - Below the tip of the iceberg
1Medizinische Klinik und Poliklinik I, Munich University Clinic, Munich, Germany; German Center for Cardiovascular Research (DZHK), Germany.
Insights
Late mortality after myocardial infarction (MI) remains high, particularly in patients with preserved ejection fraction. Cardiac autonomic dysfunction identifies high-risk individuals, prompting new preventive strategies beyond traditional implantable cardioverter-defibrillator (ICD) therapy.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Medical Device Technology
Background:
- Late mortality post-myocardial infarction (MI) remains a significant clinical challenge.
- Sudden cardiac death is a primary cause of mortality in post-MI patients.
- Current prophylactic implantable cardioverter-defibrillator (ICD) therapy is indicated for patients with left ventricular ejection fraction (LVEF) ≤35%, leaving a large patient group with LVEF >35% without specific preventive strategies.
Purpose of the Study:
- To investigate the prognostic value of cardiac autonomic dysfunction in post-MI patients with preserved LVEF (LVEF >35%).
- To identify high-risk post-MI patients with LVEF >35% using combinations of autonomic markers.
- To evaluate novel preventive strategies for high-risk post-MI patients with LVEF 36-50% and cardiac autonomic dysfunction.
Main Methods:
- Analysis of cardiac autonomic dysfunction markers in post-MI patients.
- Risk stratification of post-MI patients with preserved LVEF based on autonomic markers.
- Evaluation of the REFINE-ICD trial (traditional ICD implantation) and the SMART-MI trial (implantable cardiac monitors with remote monitoring).
Main Results:
- Cardiac autonomic dysfunction provides important prognostic information in post-MI patients with preserved LVEF.
- Combinations of autonomic markers can identify high-risk post-MI patients (LVEF >35%) with outcomes comparable to those with LVEF ≤35%.
- Ongoing trials are testing ICDs and advanced monitoring for high-risk post-MI patients with autonomic dysfunction and LVEF 36-50%.
Conclusions:
- Cardiac autonomic dysfunction is a crucial factor for risk stratification in post-MI patients with preserved LVEF.
- Novel strategies targeting autonomic dysfunction and subclinical arrhythmias are needed for high-risk post-MI patients.
- Future research and clinical trials are essential to refine preventive therapies for this vulnerable population.
Abstract:
Despite major advances in medical therapies late mortality after myocardial infarction (MI) is still high. A substantial proportion of post-MI patients die from sudden cardiac death. Prophylactic implantable-cardioverter defibrillator (ICD) therapy has been established for post-MI patients with reduced left ventricular ejection fraction (LVEF ≤35%). However, most patients who die after MI have an LVEF >35%. For this large group of patients, no specific prophylactic strategies exist. There is strong evidence that measures of cardiac autonomic dysfunction after MI provide important prognostic information in post-MI patients with preserved LVEF. Combinations of autonomic markers can identify high-risk patients after MI with LVEF >35% whose prognosis is equally worse than that of patients with LVEF ≤35%. The ongoing REFINE-ICD (NCT00673842) and SMART-MI trials (NCT02594488) test different preventive strategies in high-risk post-MI patients with cardiac autonomic dysfunction and LVEF 36-50%. While REFINE-ICD follows the traditional concept of ICD-implantation, SMART-MI uses implantable cardiac monitors with remote monitoring capabilities to sensitively detect asymptomatic, but prognostically relevant arrhythmias that could trigger specific diagnostic and therapeutic interventions.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Angina III: Clinical Manifestations and Assessment
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy